3 Biotech Penny Stocks to Watch in March 2022
Buying penny stocks be a great investment opportunity, but it’s important to understand the risks before you invest. With so many penny stocks to choose from, it can be difficult to find the best ones to buy. And when it comes to biotech penny stocks, the frequency at which they move can make profiting even more difficult.
Some popular biotech stocks right now include Citius Pharmaceuticals (NASDAQ: CTXR) and Altamira Therapeutics Ltd. (NASDAQ: CYTO) among others. With that in mind, here are a few ways to have a better chance at making money with penny stocks in 2022.
Before investing in any stock, it’s important to do your research and understand the company and its financials. This includes looking at things like earnings growth, price to earnings ratio, and debt to equity ratio. Investing in penny stocks is often riskier than investing in blue chips, so it’s important to consider these risks thoroughly before you invest.
Make sure that you have a game plan, and that you’re comfortable with the current level of volatility in the stock market. It’s also important to have a plan when investing in penny stocks. This includes setting goals and knowing when you’re going to sell. Without a plan, it’s easy to get caught up in the excitement of the stock market and to make impulsive decisions.
At the end of the day, investing in penny stocks can be easy with the right information and trading strategy. With that in mind, let’s take a look at three biotech penny stocks to watch in March 2022.
3 Biotech Penny Stocks For Your March Watchlist
- Clearside Biomedical Inc. (NASDAQ: CLSD)
- Ibio Inc. (NYSE: IBIO)
- Avenue Therapeutics Inc. (NASDAQ: ATXI)
Clearside Biomedical Inc. (NASDAQ: CLSD)
One of the bigger gainers of the day on March 11th is CLSD stock. By midday, shares of CLSD stock had shot up by over 35% to more than $1.84 per share. And this comes after a six month drop of more than 70%, which is quite substantial. So, why is CLSD stock climbing right now? The most recent news from Clearside Biomedical came on March 10th when it announced its Q4 2021 and full year financial results as well as a corporate update.
“Our suprachoroidal injection platform is a proven approach for ocular drug delivery that offers potential advantages over other types of administration. Following the approval and launch of XIPERE™, the first product approved for suprachoroidal delivery, there is a growing base of retinal specialists trained to use our proprietary SCS Microinjector.”The President and CEO of Clearside, Goerge Lasezkay, Pharm.D., J.D.
In the fourth quarter of last year, Clearside revenue and licensing income came in at $25.7 million. This is compared to $11,000 in the fourth quarter of 2020. In the fourth quarter, the company announced research and development expenses, were $3.8 million compared to $4.5 million in the previous years same quarter.
[Read More] 4 Nasdaq Penny Stocks To Buy For Under $5
All of these results are positive for the company and are the reason for CLSD stock’s gain today. And, we are also seeing major bullish sentiment in the biotech sector as a whole right now. Considering this, will CLSD be on your list of penny stocks to watch?
Ibio Inc. (NYSE: IBIO)
Another big gainer of the day so far is IBIO stock. By midday, shares of IBIO stock had shot up by over 14%. Before we get into why, it’s worth noting what IBIO does. Ibio is currently developing next-generation a range of biopharmaceuticals. In addition, the company is working on the production of a FastPharming System. This allows for vertical farming in combination with hydroponics to produce monoclonal antibodies, antigens, and certain proteins. In its most recent fiscal second quarter 2022 results posted on February 14th, the company announced some exciting updates.
“We are pleased to report that we have now added six new immuno-oncology assets to our pipeline in the six months since we announced our new drug discovery capabilities.
Our most recent addition progressed the fastest, already advancing into late-discovery stage thanks to our deployment of artificial intelligence design capabilities.
We are also leveraging our research on a novel peptide with anti-fibrotic effects into oncology by exploring its possible use in treating solid tumors with a strong fibrotic matrix.”The CEO and Chairman of IBIO, Tom Isett
In terms of fiscal data, IBIO announced that it brought in revenue of $0.2 million for the period ending on December 31st, 2021. And, it managed to bring in a consolidated net loss for the second. As stated earlier, there is a major emphasis on the biotech industry right now. This could be a contributing factor in the price increase of IBIO stock right now. With all of this considered, do you think IBIO belongs on your penny stocks watchlist?
Avenue Therapeutics Inc. (NASDAQ: ATXI)
ATXI stock is another biotech stock that is climbing right now. By midday on March 11th, shares of ATXI stock had shot up by over 6.4% to more than $0.77 per share. This is a substantial increase and one that reflects the company as a whole. The biggest news for the company came on February 16th.
On the 16th, it announced that the FDA stated it needed more data on Avenue’s IV Tramadol. This comes months after the FDA send a complete response letter regarding the company’s marketing application approval for IV Tramadol. And after this occurred, shares of ATXI plummeted. So, while there is no news that is specifically causing its gain today, it could be the result of a bullish turnaround for ATXI stock from its previous bearish momentum.
In the past twelve month period, shares of ATXI have shot down by over 88%. However, since February 25th, ATXI stock has climbed by more than 200%. This is a major shift in the price of Avenue Therapeutics stock and shows that it is working hard to continue growing. With that in mind, will ATXI be on your penny stocks watchlist?
Which Penny Stocks Are You Watching Right Now?
Is investing in penny stocks worth it? This is a question that many people ask, and the answer is not always simple. There are pros and cons to investing in penny stocks, and it’s important to understand both before making a decision.
On the positive side, penny stocks can offer the potential for high returns. And on the negative, penny stocks can offer large movement and therefore, a high chance of seeing losses. With all of this in mind, which penny stocks are you watching right now?